US (IA): Medical cannabis program saw $10M in cumulative sales in 2022

Iowa's medical cannabis program saw another year of growth in patient and provider participation, resulting in more than $10 million in sales by the end of 2022.

New data on the program was released in a report by the Iowa Cannabidiol Board in late December that offers recommendations to state lawmakers for proposed changes to the state program in the upcoming Legislative session.

Throughout 2022, the number of active cardholders certified to purchase medical cannabidiol products under the state program — which includes patients and caregivers designated to obtain products on behalf of a patient — ballooned.

Hundreds of patients obtained cards each month throughout 2022 until the total number of active patient cardholders reached nearly 15,000 individuals by November. That's compared to about 7,800 patients enrolled in December 2021.


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.